Researchers found increased odds for clinical remission on dupilumab with high blood eosinophil and fractional exhaled nitric ...
February brought policy updates and several biosimilar approvals, including the first FDA approval for an insulin aspart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback